The report on the Global Drug Discovery Informatics Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Major Drivers
- Rising incidence of chronic diseases
- Initiatives were taken up by the U.S. government
|
Major Restraints
- Lack of information technology applications
|
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on workflow, mode and services. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
The report also covers the complete competitive landscape of the global Drug Discovery Informatics market with company profiles of key players such as:
- ChemAxon
- GVK Biosciences
- Jubilant Biosys
- Selvita
- Certara
- Infosys Ltd.
- Albany Molecular Research Inc.
- Boehringer Ingelheim GmBh
- DiscoverX
- Charles River Laboratories
- Covance Inc.
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Workflow:
- Discovery Informatics
- Identification & Validation Informatics
- Lead Generation Informatics
- Development Informatics
- Lead Optimization
- FHD Preparation
- Phase IA Informatics
- Phase IB/2 Informatics
By Mode:
- In-house Informatics
- Outsourced Informatics
By Services:
- Molecular Modeling
- Sequence Analysis Platforms
- Docking
- Clinical Trial Data Management
- Other
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Drug Discovery Informatics Market has been exhibited in detail in the following chapters -
Chapter 1 Drug Discovery Informatics Market Preface
Chapter 2 Executive Summary
Chapter 3 Drug Discovery Informatics Industry Analysis
Chapter 4 Drug Discovery Informatics Market Value Chain Analysis
Chapter 5 Drug Discovery Informatics Market Analysis By Workflow
Chapter 6 Drug Discovery Informatics Market Analysis By Mode
Chapter 7 Drug Discovery Informatics Market Analysis By Services
Chapter 8 Drug Discovery Informatics Market Analysis By Geography
Chapter 9 Competitive Landscape Of Drug Discovery Informatics Companies
Chapter 10 Company Profiles Of Drug Discovery Informatics Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.